Basic info
Industry
biotechnology research
Sectors
Biotechnology
Monoclonal antibodies
Therapeutics
aGvHD
vascular microenvironment
immune microenvironment
Anticorps monoclonaux
Health Care
ophtalmologie
Anticorps thérapeutiques
Therapeutic antibodies
Date founded
2013
Funding rounds raised
Total raised
$2.7M
from 2 investors over 2 rounds
E
ELSALYS BIOTECH raised $2.7M on May 17, 2013
Investors: Sofimacpartners and Transgene